Anjum Khan

10PUBLICATIONS
77CO-AUTHORS
HaematologyMolecular targetsHaematological tumoursRespiratory diseasesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 14, 2026
A Delphi Consensus on Optimising the Care Pathway for Adult Patients With Acute Myeloid Leukaemia (AML): Strategies to Enhance Transplant Accessibility and Feasibility in the United Kingdom.

|Dec 03, 2025
Virus-induced APOBEC3 transmutagenesis in bladder cancer initiation.

George H Hatton, Sally R James, Andrew S Mason

|Sep 12, 2024
Outcomes with single-agent gilteritinib for relapsed or refractory FLT3-mutant AML after contemporary induction therapy.

Jad Othman, Angela Hwang, Maximillian Brodermann

|Jul 08, 2024
CREST-UK: Real-world effectiveness, safety and outpatient delivery of CPX-351 for first-line treatment of newly diagnosed therapy-related AML and AML with myelodysplasia-related changes in the UK.

Priyanka Mehta, Victoria Campbell, Jamie Maddox

|Feb 08, 2024
Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT.

Carmelo Gurnari, Linda Koster, Laurien Baaij

|Aug 30, 2023
Molecular MRD is strongly prognostic in patients with NPM1-mutated AML receiving venetoclax-based nonintensive therapy.

Jad Othman, Ing S Tiong, Jenny O'Nions

Pageof 2

Frequent Collaborators

4 joint publications

Rui Zhao

3 joint publications

Priyanka Mehta

2 joint publications

Jenny O'Nions

2 joint publications

Thomas P Coats